Prediction Score for Clinical Outcome of Chinese Patients with Cerebral Venous Thrombosis

References

• Idiculla PS, Gurala D, Palanisamy M, Vijayakumar R, Dhandapani S, Nagarajan E. Cerebral venous thrombosis: a comprehensive review. Eur Neurol. 2020;83(4):369–379. doi:10.1159/000509802
   PubMed Web of Science ®Google Scholar
• Silvis SM, De Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555–565. doi:10.1038/nrneurol.2017.104
   PubMed Web of Science ®Google Scholar
• Dmytriw AA, Song JSA, Yu E, Poon CS. Cerebral venous thrombosis: state of the art diagnosis and management. Neuroradiology. 2018;60(7):669–685. doi:10.1007/s00234-018-2032-2
   PubMed Web of Science ®Google Scholar
• Wang G, Yang X, Duan J, et al. Cerebral venous thrombosis: MR black-blood thrombus imaging with enhanced blood signal suppression. Am J Neurorad. 2019;40(10):1725–1730. doi:10.3174/ajnr.A6212
   PubMed Web of Science ®Google Scholar
• Ferro JM, Canhão P, Stam J, Bousser M-G, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke. 2004;35(3):664–670. doi:10.1161/01.STR.0000117571.76197.26
   PubMed Web of Science ®Google Scholar
• Ferro JM, Bacelar-Nicolau H, Rodrigues T, et al. Risk score to predict the outcome of patients with cerebral vein and dural sinus thrombosis. Cerebrovasc Dis. 2009;28(1):39–44. doi:10.1159/000215942
   PubMed Web of Science ®Google Scholar
• Kowoll CM, Kaminski J, Weiß V, et al. Severe cerebral venous and sinus thrombosis: clinical course, imaging correlates, and prognosis. Neurocrit Care. 2016;25(3):392–399. doi:10.1007/s12028-016-0256-8
   PubMed Web of Science ®Google Scholar
• Wang L, Duan J, Bian T, et al. Inflammation is correlated with severity and outcome of cerebral venous thrombosis. J Neuroinflammation. 2018;15(1):329. doi:10.1186/s12974-018-1369-0
   PubMedGoogle Scholar
• Hu Y, Meng R, Zhang X, et al. Serum neuron specific enolase may be a marker to predict the severity and outcome of cerebral venous thrombosis. J Neurol. 2018;265(1):46–51. doi:10.1007/s00415-017-8659-9
   PubMed Web of Science ®Google Scholar
• Li M, Pan L, Gao X, Hou J, Meng R, Ji X. Low diastolic blood pressure predicts good clinical outcome in patients with cerebral venous thrombosis. Front Neurol. 2021;2021:1573.
   Google Scholar
• Wu Y, Zhou L, Yao M, et al. Elevated fasting blood glucose is predictive of the severity and poor outcome in nondiabetic patients with cerebral venous thrombosis. J Neurol Sci. 2020;417:117017. doi:10.1016/j.jns.2020.117017
   PubMed Web of Science ®Google Scholar
• Aguiar de Sousa D, Pereira‐Santos MC, Serra‐Caetano A, et al. Blood biomarkers associated with inflammation predict poor prognosis in cerebral venous thrombosis: a multicenter prospective observational study. Eur J Neurol. 2021;28(1):202–208. doi:10.1111/ene.14526
   PubMed Web of Science ®Google Scholar
• Bushnaq SA, Qeadan F, Thacker T, Abbas M, Carlson AP. High-risk features of delayed clinical progression in cerebral venous thrombosis: a proposed prediction score for early intervention. Interv Neurol. 2018;7(6):297–307. doi:10.1159/000487960
   PubMed Web of Science ®Google Scholar
• Li M, Gao X, Yang Q, et al. Protocol of a multicenter cohort observational study of cerebral venous thrombosis in china mainland. Cerebrovasc Dis. 2022;2022:1–7.
   Google Scholar
• Barboza MA, Chiquete E, Arauz A, et al. A practical score for prediction of outcome after cerebral venous thrombosis. Front Neurol. 2018;9:882. doi:10.3389/fneur.2018.00882
   PubMed Web of Science ®Google Scholar
• Buyck P-J, Zuurbier SM, Garcia-Esperon C, et al. Diagnostic accuracy of noncontrast CT imaging markers in cerebral venous thrombosis. Neurology. 2019;92(8):e841–e851. doi:10.1212/WNL.0000000000006959
   PubMed Web of Science ®Google Scholar
• Silvis S, Hiltunen S, Lindgren E, et al. Cancer and risk of cerebral venous thrombosis: a case–control study. J Thromb Haemost. 2018;16(1):90–95. doi:10.1111/jth.13903
   PubMed Web of Science ®Google Scholar
• Girot M, Ferro JM, Canhão P, et al. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke. 2007;38(2):337–342. doi:10.1161/01.STR.0000254579.16319.35
   PubMed Web of Science ®Google Scholar
• Özdemir HH, Varol S, Akıl E, Acar A, Demir CF. Evaluation of cerebral venous thrombosis secondary to oral contraceptive use in adolescents. Neurol Sci. 2015;36(1):149–153. doi:10.1007/s10072-014-1914-2
   PubMed Web of Science ®Google Scholar
• Appenzeller S, Zeller CB, Annichino-Bizzachi JM, et al. Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis. Clin Neurol Neurosurg. 2005;107(5):371–378. doi:10.1016/j.clineuro.2004.10.004
   PubMed Web of Science ®Google Scholar
• Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35. doi:10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36. doi:10.1148/radiology.143.1.7063747
   PubMed Web of Science ®Google Scholar
• Zuurbier SM, Hiltunen S, Tatlisumak T, et al. Admission hyperglycemia and clinical outcome in cerebral venous thrombosis. Stroke. 2016;47(2):390–396. doi:10.1161/STROKEAHA.115.011177
   PubMed Web of Science ®Google Scholar
• Duman T, Uluduz D, Midi I, et al. A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study. J Stroke Cerebrovasc Dis. 2017;26(8):1848–1857. doi:10.1016/j.jstrokecerebrovasdis.2017.04.020
   PubMed Web of Science ®Google Scholar
• Haque A, Polcyn R, Matzelle D, Banik NL. New insights into the role of neuron-specific enolase in neuro-inflammation, neurodegeneration, and neuroprotection. Brain Sci. 2018;8(2):33. doi:10.3390/brainsci8020033
   PubMed Web of Science ®Google Scholar
• Tiwari HS, Misra UK, Kalita J, Mishra A, Shukla S. Oxidative stress and glutamate excitotoxicity contribute to apoptosis in cerebral venous sinus thrombosis. Neurochem Int. 2016;100:91–96. doi:10.1016/j.neuint.2016.09.003
   PubMed Web of Science ®Google Scholar
• Rashad S, Niizuma K, Sato-Maeda M, et al. Early BBB breakdown and subacute inflammasome activation and pyroptosis as a result of cerebral venous thrombosis. Brain Res. 2018;1699:54–68. doi:10.1016/j.brainres.2018.06.029
   PubMed Web of Science ®Google Scholar
• Forget P, Khalifa C, Defour JP, Latinne D, Van Pel MC, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10(1):12. doi:10.1186/s13104-016-2335-5
   PubMedGoogle Scholar
• Akboga YE, Bektas H, Anlar O. Usefulness of platelet to lymphocyte and neutrophil to lymphocyte ratios in predicting the presence of cerebral venous sinus thrombosis and in-hospital major adverse cerebral events. J Neurol Sci. 2017;380:226–229. doi:10.1016/j.jns.2017.07.036
   PubMed Web of Science ®Google Scholar
• Li S, Liu K, Gao Y, et al. Prognostic value of systemic immune–inflammation index in acute/subacute patients with cerebral venous sinus thrombosis. Stroke Vasc Neurol. 2020;5(4):368–373. doi:10.1136/svn-2020-000362
   PubMedGoogle Scholar
• Bushnaq S, Thacker T, Abbas M, Qeadan F, Carlson A. O-035 Risk factors for delayed deterioration after cerebral venous thrombosis: a model to identify patients for early aggressive endovascular therapy. J Neurointerv Surg. 2017;9:A20–A21.
   Google Scholar